The group’s principle activity is to commercialize a patented technology that allows for the polymerization of a broad range of pharmaceutical compounds. The group’s technology PolymerDrug(TM) technology platform creates a wide variety of pharmaceutical and medical device product opportunities and is expected to confer significant advantages to many marketed products including those currently under development. The group operates from United States.
